Contents

Current Medicinal Chemistry, Volume 16 - Number 33

Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs

, 16(33): 4345 - 4360

G. D. Kolovou, K. K. Anagnostopoulou, P. M. Kostakou and D. P. Mikhailidis


DOI: 10.2174/092986709789712853




Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?

, 16(33): 4361 - 4373

R. Fanciullino and J. Ciccolini


DOI: 10.2174/092986709789712916




Chemogenomic Strategies to Expand the Bioactive Chemical Space

, 16(33): 4374 - 4381

E. Jacoby and A. Mozzarelli


DOI: 10.2174/092986709789712862




Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection

, 16(33): 4382 - 4398

D. Morin, R. Assaly, S. Paradis and A. Berdeaux


DOI: 10.2174/092986709789712871




The Medicinal Chemistry of Peptides

, 16(33): 4399 - 4418

J. J. Nestor Jr.


DOI: 10.2174/092986709789712907




Protein Cysteine Modifications: (1) Medicinal Chemistry for Proteomics

, 16(33): 4419 - 4444

N. Nagahara, T. Matsumura, R. Okamoto and Y. Kajihara


DOI: 10.2174/092986709789712880




Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET

, 16(33): 4445 - 4461

G. Lendvai, S. Estrada and M. Bergstrom


DOI: 10.2174/092986709789712844




Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide

, 16(33): 4462 - 4480

S. Bourgault, D. Vaudry, A. Dejda, N. D. Doan, H. Vaudry and A. Fournier


DOI: 10.2174/092986709789712899




The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine

, 16(33): 4481 - 4489

B. Malhotra, K. Gandelman, R. Sachse, N. Wood and M. C. Michel


DOI: 10.2174/092986709789712835




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science